Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Revista Espanola De Enfermedades Digestivas|April 26, 2019
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel diseaseGregorio J Martínez-Romero, Ana Alvariño, Esther Hinojosa, et al.Revista Iberoamericana De Micologia|December 13, 2016
Disseminated aspergillosis in an immunocompetent patient with detectable bis(methylthio)gliotoxin and negative galactomannanMatxalen Vidal-García, Pilar Sánchez-Chueca, María Pilar Domingo, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|May 30, 2013
Long-term outcome of 'long-term liver transplant survivors'Angel Rubín, Cristina Sánchez-Montes, Victoria Aguilera, et al.Gastroenterologia Y Hepatologia|October 14, 2019
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosisManuel Barreiro-de Acosta, Ana Gutierrez, Iago Rodríguez-Lago, et al.Gastroenterologia Y Hepatologia|July 23, 2018
Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agentsMarisa Iborra, Belén Beltrán, Nuria Maroto, et al.Journal of Fungi (Basel, Switzerland)|December 3, 2020
Agrobacterium tumefaciens-Mediated Transformation of Fonsecaea monophora and Fonsecaea erecta for Host-Environment Interaction StudiesCristina Isabel Ferrer Villena, Renata Rodrigues Gomes, Larissa Fernandes, et al.Gastroenterologia Y Hepatologia|July 1, 2020
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: TreatmentManuel Barreiro-de Acosta, Ignacio Marín-Jimenez, Iago Rodríguez-Lago, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 21, 2024
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, Miguel Ángel Moya Hernández, Evdochia Adoamnei, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 7, 2025
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer groupManuel Sánchez Cánovas, Javier López Robles, Francisco José García Verdejo, et al.European Journal of Internal Medicine|August 5, 2022
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basisSilvia García Adrián, Adán Rodríguez González, Eva Martínez de Castro, et al.Pageof 3